Inactive Instrument

Press Releases Ampliphi Biosciences Corp Nyse

Equities

US03211P3010

Press Releases

Unlock all the news: Be the first to know and act before the market!

Armata Pharmaceuticals : Shareholder Meeting - Form 8-K	22/03	PU
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update	15/11	AQ
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus	27/23/27	AQ
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference	22/23/22	AQ
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update	15/23/15	AQ
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics	12/23/12	AQ
Armata Pharmaceuticals Announces Oral Presentation Detailing Results from the Phase 1b/2a SWARM-P.a. Clinical Trial at the 6th World Conference on Targeting Phage Therapy	01/23/01	AQ
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update	12/23/12	AQ
ARMATA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	12/23/12	AQ
ARMATA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)	06/23/06	AQ
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update	17/23/17	AQ
ARMATA PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	17/23/17	AQ
ARMATA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	06/23/06	AQ
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC	11/23/11	AQ
Armata Pharmaceuticals : Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC - Form 8-K	10/23/10	PU
ARMATA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	10/23/10	AQ
ARMATA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	20/22/20	AQ
Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage	29/22/29	AQ
ARMATA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	18/22/18	AQ
Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update	10/22/10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Ampliphi Biosciences Corp Nyse

Equities

US03211P3010

Press Releases

Filters